Related Experiment Videos
NMDA channel blockers: memantine and amino-aklylcyclohexanes--in vivo characterization
W Danysz1, C G Parsons, G Quack
1Department of Pharmacological Research, Merz+Co, Frankfurt/Main, Federal Republic of Germany.
Amino Acids
|October 12, 2000
Abstract:
The previous overviews provided the basis for better therapeutic efficacy/tolerability of low to moderate affinity NMDA channel blockers. This prediction finds support in in vitro studies comparing protective and plasticity impairing effects (therapeutic vs. side-effect) of memantine and (+)MK-801. In fact it turned out that memantine had a far better therapeutic index. But can it be confirmed in the in vivo situation?